Clinical trials
Terminated Multiple Myeloma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Teva Branded Pharmaceutical Products R&D LLC | 2 |
| Celgene | 1 |
| Guangzhou Bio-gene Technology Co., Ltd | 1 |
| HitGen Inc. | 1 |
| Nanjing Legend Biotech Co. | 1 |
| Second Affiliated Hospital of Xi'an Jiaotong University | 1 |
| Shanghai EpimAb Biotherapeutics Co., Ltd. | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| Takeda | 1 |
| Zhujiang Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 11 |
| Recurrence | 3 |
| Hematologic Neoplasms | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.